Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study)
在韩国 2 型糖尿病合并血脂异常患者中,换用依折麦布 10 mg/瑞舒伐他汀 2.5 mg 的疗效和安全性:一项多中心前瞻性研究(EROICA 研究)
期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.70258
Hong, Sangmo; Kim, Won J; Kim, Sungrae; Park, Jung H; Kang, Eun S; Moon, Min K; Kim, Jae T; Mok, Ji-Oh; Lee, Ki Y; Park, Cheol-Young; Lee, Chang B